×

Access Whitepaper

First Name
Last Name
Company
Thank you!
Error - something went wrong!
   

Part 1: Clinical Trials in the Era of COVID-19: Changes You Need to Make Now

May 14, 2020
From protocol amendments to participant recruitment and retention, the impact of COVID-19 could be enormous. What can you do to minimize the disruption to your ongoing, or upcoming, clinical trial? Our panel of experts from NYU Langone Medical Center and WCG discuss ways to reduce the impact of this pandemic on your studies to keep them on track.
Previous Flipbook
Part 2: The Necessary Changes that Sites, Institutions and Research Participants are Considering During the COVID-19 Crisis
Part 2: The Necessary Changes that Sites, Institutions and Research Participants are Considering During the COVID-19 Crisis

Next Flipbook
The Power to Pivot: Decoding CNS Trials with Data Analytics
The Power to Pivot: Decoding CNS Trials with Data Analytics

In this interview, Jesse Kooker, MPH, VP of Clinical Data Sciences at WCG's MedAvante-ProPhase, looks at th...

Request a Genetics in Clinical Trials training session

What You'll Learn